Abu Dhabi Investment Authority in Medline Inc.
Completed. First disclosed February 11, 2026, in a Schedule 13G (source).
- Investor
- Abu Dhabi Investment Authority (United Arab Emirates)
- Target
- Medline Inc. (EDGAR CIK 2046386)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 3841)
- First disclosed
- February 11, 2026, Schedule 13G
- Amount
- Not stated
- Stake at first disclosure
- 5.9%
- Latest stated stake
- 4.9% (May 7, 2026)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| February 11, 2026 | Schedule 13G | 5.9% | View |
| May 7, 2026 | Schedule 13G/A | 4.9% | View |
Cite: Middle East Forum, “Abu Dhabi Investment Authority in Medline Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/adia-medline-inc-2046386/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.